Dominion Aesthetic Technologies, Inc.
- Industry
- Medical Devices
- Founded Year
- 2016
- Headquarters
- Houston, Texas
- Employee Count
- 0
Key People
- Cooper C. Collins - Chief Executive Officer
- Gerry Sheridan - Chief Financial Officer
- Janet Campbell - Chairman of the Board
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with significant industry expertise.
The CEO, Cooper C. Collins, and CFO, Gerry Sheridan, bring substantial experience to the company, enhancing its strategic direction and financial management.
- Clinical Need
-
Aspect: Strong
Summary: EON addresses a significant demand for non-invasive body contouring solutions.
The device offers a touchless, robotic solution for fat reduction, catering to patients seeking non-surgical alternatives with minimal downtime.
- Competition
-
Aspect: Somewhat crowded
Summary: The body contouring market has several established players, but EON's unique features provide a competitive edge.
While the market is competitive, EON's touchless technology and robotic precision differentiate it from other devices.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of EON involved integrating advanced technologies, but the challenges were manageable.
The integration of a 21" touch screen and robotic arm required innovative solutions, but the development process was well-executed.
- Patent
-
Aspect: Strong
Summary: EON is protected by multiple patents, ensuring a strong intellectual property position.
The device holds patents in the U.S. and internationally, covering its unique touchless and robotic technologies.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding to support its commercialization efforts.
A $23.7 million Series B financing round was closed to accelerate manufacturing and commercialization.
- Regulatory
-
Aspect: 510k/PMA
Summary: EON has received multiple FDA clearances for various treatment areas.
The device is FDA-cleared for non-invasive lipolysis of the abdomen, flanks, back, and thighs.
Opportunity Rollup
- Odds of Success
- 3.3
- Peak Market Share
- 4.35
- Segment CAGR
- 6.3%
- Market Segment
- Aesthetic Devices
- Market Sub Segment
- Non-invasive Body Contouring
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.65 |
| 3 | 1.52 |
| 4 | 3.05 |
| 5 | 4.35 |
Key Takeaway
Dominion Aesthetic Technologies' EON device offers a unique, touchless solution in the growing non-invasive body contouring market, supported by strong leadership and substantial funding.